owen mumford logo

Espace réservé aux professionnels de santé.

Cet espace contient des informations sur des dispositifs médicaux, dont l'utilisation est réservée aux professionnels de la santé. En application de la loi du 29 décembre 2011 relative au renforcement de la sécurité sanitaire, je certifie être un professionnel de santé et être donc autorisé à accéder a ces informations »

Faire progresser le domaine du diabète

Nos stylos injecteurs et nos aiguilles sont conçus pour faciliter l’administration de médicaments injectables et pour favoriser une bonne technique d’injection.

Owen Mumford possède une riche expérience dans le domaine des soins du diabète, en présentant le premier stylo injecteur d’insuline automatique réutilisable au monde. Nous nous engageons constamment à travailler avec des partenaires pharmaceutiques et des dispositifs médicaux de premier plan, des professionnels de la santé et des patients afin de faciliter la gestion des schémas de traitement du diabète.

ateria-safecontrol

Ateria® SafeControl®

aiguille de stylo avec sécurité active conçue pour protéger ceux qui administrent les injections, avec un juste équilibre entre sécurité et contrôle pendant le processus d’injection.
Read more
unifine-pentips

Unifine® Pentips

des aiguilles de stylo de haute qualité conçues pour plus de confort
Read more
autopen

Autopen®

un stylo injecteur d’insuline, à cartouche, réutilisable, qui fournit une dose d’insuline prédéfinie par application d’une force minimale ; facilite le traitement quel que soit l’âge du patient.
Read more
unifine-pentips-plus

Unifine® Pentips Plus

la première aiguille de stylo tout-en-un équipée d’un système de retrait intégré.
Read more
tri-care

Tricare

des aiguilles de stylo conçues pour un usage quotidien.
Read more
Autoject 2

Autoject 2

une aide à l’injection automatique qui rend l’auto-injection par seringue simple, pratique et plus facile à gérer.
Read more

Diabetes care safety pen needles and medical devices

An estimated 540 million adults worldwide live with diabetes. That number is set to rise to 783 million or one in eight adults by 2045 [1]. With prevalence rising, those with diabetes need treatment regimens and medical devices that make it easier to manage their condition.

At Owen Mumford, we have meticulously developed our range of diabetes care devices including injection pens and needles to provide safe and efficient treatment for those living with diabetes and the healthcare professionals (HCPs) that treat them.

In 1972, our team introduced the Autolet®, the world s first automatic lancing device, making blood glucose monitoring possible in the home for the first time. In the 50 years since then, we have nurtured an innovative design and production process to create leading diabetes medical devices. These have been designed and developed following research into pharmaceutical partners, HCPs and patients, making diabetes treatment regimens easier to manage.

Eliminate needle stick injuries with safety pen needles

Up to 69.4%
HCPs globally have experienced NSIs 2
Up to 36%
of NSIs are caused by hypodermic injections 2
<span class="invisible-text">up to</span> 81%
HCPs agree that a safety pen needle increases protection against NSIs compared to conventional pen needles 3

Discover our range of diabetes care medical devices

Find the right medical devices for patients with diabetes and those who administer injections.

Unifine® SafeControl®

click
Image

Unifine® Pentips® Plus

click

Unifine® Pentips®

click

TriCare

click
Autopen

Autopen®

click

Autoject®2

click

Owen Mumfords world first diabetes innovations

  • Unifine® SafeControl®
  • Autopen®
  • Autolet®
Unifine® SafeControl®
Unifine® SafeControl®
Our 2019 research into the
experience of patients with
pen needles in daily practice
led to the creation of the
first of its kind safety pen
needle designed to provide
a balance of safety and
control during the injection
process for healthcare
professionals.
Autopen®
Autopen®
By 1982 we created an
insulin delivery pen which
patients could use to dial
a dose and inject
themselves at any time. A
unique, side mounted
release button was
created that required
considerably less force to
operate than other
manual injection devices.
Autolet®
Autolet®
In 1978 we introduced
the worlds first
automatic lancing device
to take a capillary blood
sample by simply
pricking the skin.

Making blood glucose
monitoring possible in
the home for the first
time.

Explore our other treatments and device categories

Venepuncture and blood collection

click

Pelvic health

click

Point of care testing

click

FURTHER READING

Active and passive: Safety devices and diabetes care

click
How Owen Mumford's intuitive safety devices are designed to help reduce sharps injuries

How Owen Mumford's intuitive safety devices are designed to help reduce sharps injuries

click

New safety pen needle protects patients and healthcare professionals

click

Partner with Owen Mumford for your diabetes care medical devices

Owen Mumford has extensive experience partnering with leading pharmaceutical organisations to deliver high quality medical devices for diabetes care.

Contact us and our expert team of associates will be able to help you to find the diabetes devices, products and services best suited for your needs.

Your Enquiry

CAPTCHA Cette question sert à vérifier si vous êtes un visiteur humain ou non afin d'éviter les soumissions de pourriel (spam) automatisées.

References

  1. International Diabetes Federation. IDF Diabetes Atlas, 10th edn. Brussels, Belgium: 2021. Available at: https://www.diabetesatlas.org
  2. Cooke CE, Stephens JM (2017) Clinical, economic, and humanistic burden of needlestick injuries in healthcare workers. Med Devices Auckl NZ 10:225–235.
  3. Project Saturn A (2017) Online study commissioned with an independent market research agency. Data on file.
  4. D'Souza D, Empringham J, Pechlivanoglou P, Uleryk EM, Cohen E, Shulman R. Incidence of Diabetes in Children and Adolescents During the COVID 19 Pandemic: A Systematic Review and Meta-Analysis. JAMA Netw Open. 2023;6(6):e2321281. doi:10.1001/jamanetworkopen.2023.21281

Connectez-vous avec nous

Contact Us

Get in touch with us!

contact